Market Research Logo

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat. The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
...Show More ...Show Less


Pharmaceuticals Industry Research & Market Reports

  • La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • Zambon Company SpA - Strategic SWOT Analysis Review

    ... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More

  • Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review

    ... company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. ... Read More

  • BioClinica Inc - Strategic SWOT Analysis Review

    ... company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. ... Read More

  • Celldex Therapeutics Inc (CLDX) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • CTI BioPharma Corp (CTIC) - Financial and Strategic SWOT Analysis Review

    ... company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. ... Read More

  • Cytori Therapeutics Inc (CYTX) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • Ukraine Pharmaceuticals & Healthcare Q3 2019

    ... healthcare services, and the imminentimplementation of the National Health System should boost access to services. However, we note that poor administration willcontinue to hinder positive outcomes and the short-term impact of reform may be muted. Read More

  • Chile Pharmaceuticals & Healthcare Q3 2019

    ... intentionsto introduce compulsory licensing will significantly decrease the market’s attractiveness to innovative drugmakers. Concernsregarding poor regulatory data protection and weak patent enforcement further reduce attractiveness. We believe that intellectualproperty concerns are unlikely to be addressed ... Read More

  • C-X-C Chemokine Receptor Type 2 - Pipeline Review, H1 2019

    ... or CXCR2) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report C-X-C Chemokine Receptor Type 2 - Pipeline Review, ... Read More

  • South Africa Pharmaceuticals & Healthcare Q3 2019

    ... the regulatoryenvironment, reformed intellectual property policy and the expansion of healthcare coverage through the implementation of theNational Health Insurance Scheme are ongoing tasks that if implemented successfully in the long term will further boost theattractiveness ... Read More

  • Diabetic Nephropathy - Pipeline Review, H1 2019

    ... pipeline landscape. Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid ... Read More

  • Contrast Induced Nephropathy - Pipeline Review, H1 2019

    ... Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape. Contrast-induced nephropathy (CIN) is defined as the impairment of renal function (measured as either a 25%increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL ... Read More

  • Arterial Thrombosis - Pipeline Review, H1 2019

    ... landscape. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms, arterial thrombosis ... Read More

  • Australia Pharmaceuticals & Healthcare Q3 2019

    ... to services, will continue tosupport this potential. We caution that market access is now challenging as authorities use a range of cost-containment measuresand downward price pressures as a means of controlling state spending on medicines. Read More

  • Finland Pharmaceuticals & Healthcare Q3 2019

    ... healthcare reformsand creating an uncertain market for drugmakers and healthcare providers. Nonetheless, as with many of its Western Europeanpeers, an ageing population and high per capita spending will ensure the demand for innovative medicines remain ... Read More

  • Lithuania Pharmaceuticals & Healthcare Q3 2019

    ... to dispensedrugs to outpatients will continue to support volume growth. On the other, the authorities remain keen on reducing public sectorspending on medicines and medical supplies through the further development of the consolidated public procurementprogrammes. Read More

  • Bone Marrow Transplant Rejection - Pipeline Review, H1 2019

    ... Bone Marrow Transplant Rejection (Immunology) pipeline landscape. Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient's body. ... Read More

  • Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019

    ... of the Granulomatosis with Polyangiitis (Wegener Polyangiitis) (Immunology) pipeline landscape. Wegener Polyangiitis is an uncommon disorder that causes inflammation of blood vessels. This inflammation restricts blood flow to various organs. Signs and symptoms include constantly ... Read More

  • Primary Hyperoxaluria - Pipeline Review, H1 2019

    ... System And Sex Hormones) pipeline landscape. Primary hyperoxaluria is a rare condition characterized by recurrent kidney and bladder stones. It results from the overproduction of a substance called oxalate. Symptoms include blood in the urine, ... Read More

  • Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

    ... a receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. ... Read More

  • Grass Pollen Allergy - Pipeline Review, H1 2019

    ... Allergy (Immunology) pipeline landscape. Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in ... Read More

  • C-X-C Chemokine Receptor Type 4 - Pipeline Review, H1 2019

    ... 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - C-X-C chemokine receptor type 4 or CD184 is a protein encoded by the CXCR4 gene. It is a receptor for ... Read More

  • Dyslipidemia - Pipeline Review, H1 2019

    ... is defined as elevation of the total cholesterol, the bad low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the good high-density lipoprotein (HDL) cholesterol concentration in the blood. Numerous factors and ... Read More

5 6 7 8 10 12 13 14